Cell Biology
-
Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro
This article has 17 authors:Reviewed by ScreenIT
-
SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation
This article has 19 authors:Reviewed by ScreenIT
-
Sequences in the cytoplasmic tail of SARS-CoV-2 Spike facilitate expression at the cell surface and syncytia formation
This article has 6 authors:Reviewed by ScreenIT
-
Evaluation of nafamostat mesylate safety and inhibition of SARS-CoV-2 replication using a 3-dimensional human airway epithelia model
This article has 2 authors:Reviewed by ScreenIT
-
Kidney injury molecule-1 is a potential receptor for SARS-CoV-2
This article has 12 authors:Reviewed by ScreenIT
-
Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors
This article has 26 authors:Reviewed by ScreenIT
-
Degradation of SARS-CoV-2 receptor ACE2 by the E3 ubiquitin ligase Skp2 in lung epithelial cells
This article has 14 authors:Reviewed by ScreenIT
-
Biological activity-based modeling identifies antiviral leads against SARS-CoV-2
This article has 20 authors:Reviewed by ScreenIT
-
Direct Exposure to SARS-CoV-2 and Cigarette Smoke Increases Infection Severity and Alters the Stem Cell-Derived Airway Repair Response
This article has 19 authors:Reviewed by ScreenIT
-
Hydroxychloroquine: mechanism of action inhibiting SARS-CoV2 entry
This article has 4 authors:Reviewed by ScreenIT